Overview
The Human PD-L1 Inhibitor I is a vital peptide for your research on immune checkpoints, particularly focusing on the PD-1 receptor and its ligand PD-L1. These components are essential in regulating T cell activation and play a significant role in various immune responses, including tolerance and immunopathology. Tumor cells often exploit PD-L1 overexpression to evade immune detection, making this inhibitor a key tool for studying cancer immunotherapy and the intricate dynamics of immune regulation.
Key Features
- Inhibits PD-1/PD-L1 binding, enhancing your research on immune checkpoint modulation.
- Designed with specific anchor residues (WDY) that significantly affect binding efficacy.
- Ideal for therapeutic research related to cancer and immune responses.
- Offers consistent performance for reliable replication of results.
- Available in a convenient 1 mg vial for flexible experimentation.
Specifications
| Item | Details |
|---|---|
| Product Name | Human PD-L1 Inhibitor I |
| Category | Peptides |
| Quantity | 1 mg |
FAQ
What applications can I use the Human PD-L1 Inhibitor I for?
You can utilize the Human PD-L1 Inhibitor I in studies focused on immune checkpoint blockade, particularly in examining T cell activation and its implications in cancer treatment. Its design allows for effective binding inhibition, making it suitable for various cellular assays.
How does the binding mechanism work for this peptide?
The Human PD-L1 Inhibitor I specifically targets the interaction between PD-1 and PD-L1 by binding to the PD-1 receptor. Its anchor residues, WDY, enhance its ability to inhibit the PD-1/PD-L1 complex formation, facilitating research into immunotherapy strategies.
Is this peptide suitable for in vivo studies?
The Human PD-L1 Inhibitor I is primarily designed for in vitro applications. However, its characteristics may allow for exploration in in vivo settings depending on your experimental design and objectives.
For further exploration into related products, consider our selection of PKG Substrate [RKRSRAE] and other peptides that might enhance your research capabilities.
Get your Human PD-L1 Inhibitor I today and provide your research with the tools it needs to explore vital immune interactions.




Reviews
There are no reviews yet.